New insights from DAPA-CKD indicate that dapagliflozin modulates key pathways related to kidney outcomes
- DOI
- 10.1016/j.kint.2026.06.043
- Published
- 2026-10
- Container
- Kidney International
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.kint.2026.06.043,
title = {New insights from DAPA-CKD indicate that dapagliflozin modulates key pathways related to kidney outcomes},
author = {Mark André de la Rambelje and Niels Jongs and Peter J. Greasley and Rasmus Agren and Peter Rossing and David C. Wheeler and Ann Hammarstedt and C. David Sjöström and Adriaan A. Voors and Hiddo J.L. Heerspink},
year = {2026},
journal = {Kidney International},
doi = {10.1016/j.kint.2026.06.043},
url = {https://doi.org/10.1016/j.kint.2026.06.043}
}RIS
TY - JOUR TI - New insights from DAPA-CKD indicate that dapagliflozin modulates key pathways related to kidney outcomes AU - Mark André de la Rambelje AU - Niels Jongs AU - Peter J. Greasley AU - Rasmus Agren AU - Peter Rossing AU - David C. Wheeler AU - Ann Hammarstedt AU - C. David Sjöström AU - Adriaan A. Voors AU - Hiddo J.L. Heerspink PY - 2026 JO - Kidney International DO - 10.1016/j.kint.2026.06.043 UR - https://doi.org/10.1016/j.kint.2026.06.043 ER -
APA
Rambelje, M. A. D. L., Jongs, N., Greasley, P. J., Agren, R., Rossing, P., Wheeler, D. C., Hammarstedt, A., Sjöström, C. D., Voors, A. A., & Heerspink, H. J. (2026). New insights from DAPA-CKD indicate that dapagliflozin modulates key pathways related to kidney outcomes. Kidney International. https://doi.org/10.1016/j.kint.2026.06.043
Source records
- crossref · retrieved 2026-09-25T23:31:27.172Z